Cargando…
Crosstalk between Prostate Cancer Cells and Tumor-Associated Fibroblasts Enhances the Malignancy by Inhibiting the Tumor Suppressor PLZF
Although prostate cancer is clinically manageable during the early stages of progression, metastatic progression severely compromises the prognosis and leads to mortality. Constitutive activation of STAT3 has been connected to prostate cancer malignancy, and abolishing the STAT3 activity may diminis...
Autores principales: | Noh, Kum Hee, Jeong, Ae Jin, Lee, Haeri, Lee, Song-Hee, Yi, Eunhee, Chang, Pahn-Shick, Kwak, Cheol, Ye, Sang-Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281005/ https://www.ncbi.nlm.nih.gov/pubmed/32349303 http://dx.doi.org/10.3390/cancers12051083 |
Ejemplares similares
-
Role of PLZF as a tumor suppressor in prostate cancer
por: Jin, Yang, et al.
Publicado: (2017) -
Shape-shifting and tumor suppression by PLZF
por: Hobbs, Robin M., et al.
Publicado: (2010) -
STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model
por: Kim, Byung-Hak, et al.
Publicado: (2020) -
Loss of PLZF Expression in Prostate Cancer by Immunohistochemistry Correlates with Tumor Aggressiveness and Metastasis
por: Xiao, Guang-Qian, et al.
Publicado: (2015) -
[Corrigendum] Tumor suppressor PLZF regulated by lncRNA ANRIL suppresses proliferation and epithelial mesenchymal transformation of gastric cancer cells
por: Wang, Jun-Bin, et al.
Publicado: (2023)